Key result
Plasma levels of RBP4 showed no association with NT-proBNP levels and cannot be considered an independent biomarker of heart muscle dysfunction in older adults.
Why the study?
Is plasma RBP4 associated with NT-proBNP levels in older patients?
Cross-Sectional (n=2,826)
Is plasma RBP4 associated with NT-proBNP levels in older patients?
Plasma RBP4 levels are affected by GFR but are not independently associated with NT-proBNP, suggesting RBP4 is not a reliable independent biomarker for heart muscle dysfunction in older adults.
Answers are grounded in this paper and cite their sources.
RBP4 adds no value for assessing cardiac dysfunction in older adults; leaves open its role in other cardiorenal research.
BACKGROUND/AIM: Elevated plasma concentration of retinol-binding protein 4 (RBP4) has recently emerged as a potential new risk factor for cardiovascular diseases, including hypertension (HT) and coronary artery disease (CAD). Limited data suggest that RBP4 promotes inflammatory damage to cardiomyocytes and participates in the development of heart failure (HF). This study aimed to analyze the relationship between concentrations of plasma RBP4 and serum N-terminal proBNP (NT-proBNP), a powerful biomarker of left ventricle dysfunction, in the older Polish population. METHODS: The study sample consisted of 2,826 (1,487 men) participants of the PolSenior study, aged 65 years and older, including a subgroup hospitalized for HF (n = 282). In all subjects, plasma concentrations of RBP4, interleukin-6 (IL-6), serum level of NT-proBNP, and hs-CRP were measured. Additionally, BMI, estimated glomerular filtration rate (eGFR), and HOMA-IR were calculated. The prevalence of HT, CAD, atrial fibrillation (AF), and medication were considered as potential confounders. RESULTS: Similar RBP4 levels were found in subjects with NT-proBNP < 125 and ≥125 ng/mL, with and without AF, and in the subgroups hospitalized for HF with and without AF. Regression analysis revealed no association between log10(NT-proBNP) and log10(RBP4). Plasma levels of RBP4 were increased by HT occurrence and diuretic therapy, while diminished with regard to female gender, age, eGFR values, AF, and IL-6 levels. CONCLUSION: Our results show that RBP4 is affected by GFR but cannot be considered as an independent biomarker of heart muscle dysfunction.
No takes yet. Share an insight, caveat, or question.
Majerczyk et al. (2018) conducted a cross-sectional in Heart Failure (n=2,826). Retinol-binding protein 4 (RBP4) was evaluated on Relationship between concentrations of plasma RBP4 and serum NT-proBNP. Plasma levels of RBP4 showed no association with NT-proBNP levels and cannot be considered an independent biomarker of heart muscle dysfunction in older adults.
Synapse has enriched 10 related papers. Consider them for comparative context: